CoronavirusCovid-19Health

Pfizer Receives FDA’s Nod to Provide COVID-19 Vaccine to Younger Teens

On Monday, the Food and Drug Administration (FDA) authorized the use of the COVID-19 made by Pfizer and its German partner, BioNTech, for younger teens, declaring it as both safe and effective. With the recent decision, youth ages 12 to 15 could qualify for shots within days.

Just last week, President Joe Biden said 20,000 pharmacy locations nationwide remain prepared to begin vaccinating adolescents once the necessary approvals come through.

Shots also will be available soon through pediatricians’ offices, the president said. “And if teens are on the move this summer, they can get their first shot in one place and a second shot elsewhere.”

Older teens, ages 16 and 17, have been allowed to get the Pfizer-BioNTech vaccine since its authorization in December. The other two vaccines authorized for use in the U.S., from Moderna and Johnson & Johnson, remain unavailable to minors as studies continue.

“Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic,” said Janet Woodcock, acting FDA commissioner in a statement Monday. “Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our COVID-19 vaccine emergency use authorizations.”

Although such cases remain rare, adolescents can become seriously ill from COVID-19 and can spread it to others.

“My hope is that if the vaccine is authorized, parents will take advantage of it and get their kids vaccinated,” Biden said.

From March 1, 2020, to April 30, 2021, about 1.5 million adolescents, ages 11-17, tested positive for COVID-19, according to the Centers for Disease Control and Prevention.

Many parents indicate they’re anxious to get their children vaccinated so their families can safely visit older relatives and their teens can get back to school and extracurricular and social activities.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Adblock Detected

Please consider supporting us by disabling your ad blocker